comparemela.com

Latest Breaking News On - Michael ullmann - Page 10 : comparemela.com

State AGs urge support for landmark $26 billion opioid settlement

State AGs urge support for landmark $26 billion opioid settlement By Nate Raymond Reuters (Reuters) -A group of state attorneys general unveiled on Wednesday a landmark $26 billion settlement with large drug companies for allegedly fueling the deadly nationwide opioid epidemic, but the deal still requires support from thousands of local governments. Under the settlement proposal, the three largest U.S. drug distributors, McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp, are expected to pay a combined $21 billion, while drugmaker Johnson & Johnson would pay $5 billion. There s not enough money in the world, frankly, to address the pain and suffering, said Connecticut Attorney General William Tong, adding that the money will help where help is needed.

US state officials urge support for landmark $26 billion opioid settlement

By Nate Raymond (Reuters) -A group of state attorneys general unveiled on Wednesday a landmark $26 billion settlement with large drug companies for allegedly fueling the deadly nationwide opioid epidemic, but the deal still requires support from thousands of local governments. Under the settlement proposal, the three largest U.S. drug distributors McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp are expected to pay a combined $21 billion, while drugmaker Johnson & Johnson would pay $5 billion. The money is expected to be used on addiction treatment, family support, education and other social programs. There s not enough money in the world, frankly, to address the pain and suffering, said Connecticut Attorney General William Tong, but added that the money will help where help is needed.

Drug companies, US states reach $26 billion settlement over opioid crisis

Drug companies, US states reach $26 billion settlement over opioid crisis Issued on: 22/07/2021 - 01:25 The opioids epidemic in the United States has caused more than 500,000 deaths in the last 20 years © Eric Baradat, AFP/File 4 min Prosecutors from several US states on Wednesday unveiled a sweeping proposed settlement under which four pharmaceutical companies accused of fueling the country’s opioid epidemic would pay up to $26 billion to resolve thousands of claims in federal and state courts. Advertising Read more Under the proposed agreement, three drug distributors McKesson, Cardinal Health and Amerisource Bergen along with drugmaker Johnson & Johnson, would pay to resolve some 4,000 claims as well as finance prevention and treatment programs, said New York Attorney General Letitia James.

State AGs Unveil Landmark $26 Billion Opioid Settlement

State AGs Unveil Landmark $26 Billion Opioid Settlement A group of state attorneys general unveiled on Wednesday a landmark $26 billion settlement with large drug companies for allegedly fueling the deadly nationwide opioid epidemic, but the deal still requires support from thousands of local governments. Under the settlement proposal, the three largest U.S. drug distributors, McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp, are expected to pay a combined $21 billion, while drugmaker Johnson & Johnson (J&J) would pay $5 billion. “There’s not enough money in the world, frankly, to address the pain and suffering,” said Connecticut Attorney General William Tong, adding that the money will “help where help is needed.”

Afternoon Briefs: $26B opioid settlement proposed; lawyer resigns after he s accused of nude cleaning proposal

Afternoon Briefs: $26B opioid settlement proposed; lawyer resigns after he s accused of nude cleaning proposal   Proposed $26B opioid settlement announced A group of state attorneys general have announced a proposed $26 billion settlement between states and four companies that make and distribute opioids. Johnson & Johnson is among the companies that would be released from liability as result of the settlement, which requires it to stop selling opioids. The settlement will support state and local efforts to address the opioid crisis, said Michael Ullmann, Johnson & Johnson executive vice president, in a statement. (The New York Times, New York attorney general press release)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.